The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Discovering Natural Product Modulators to Overcome Multidrug Resistance in Cancer Chemotherapy
Open accessAbstract
Multidrug resistance caused by the overexpression of ABC drug transporters is a major obstacle in clinical cancer chemotherapy. For several years, it appeared that direct inhibition of ABC transporters would be the cheapest and most efficient way to combat this problem. Unfortunately, progress in finding a potent, selective inhibitor to modulate ABC transporters and restore drug sensitivity in multidrug-resistant cancer cells has been slow and challenging. Candidate drugs should ideally be selective, potent and relatively non-toxic. Many researchers in recent years have turned their attention to utilizing natural products as the building blocks for the development of the next generation of inhibitors, especially after the disappointing results obtained from inhibitors of the first three generations at the clinical trial stage. The first step is to discover natural substances (distinct from the first three generation inhibitors) that are potent, selective and relatively non-toxic in order to be used clinically. Here, we present a brief overview of the prospect of using natural products to modulate the function of ABC drug transporters clinically and their impact on human physiology and pharmacology. Keywords: ATP-binding cassette transporters, bioavailability, chemotherapy, modulators, multidrug resistance, natural products, inhibition of ABC transporters, drug sensitivity, non-toxic, ABC drug transporters, MDR, ATP hydrolysis, knock-out mouse models, gleevec
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bioavailability of curcumin: Problems and promises
Anand, P., Kunnumakkara, A. B., Newman, R. A., & Aggarwal, B. B. (2007) · Molecular Pharmaceutics · doi:10.1021/mp700113r · Cited by 5,543 · cited 1×
“Therefore, several approaches have been investigated to improve the delivery of curcumin in our system [44], including the use of liposomal curcumin [45]; curcumin nanoparticles [46, 47], curcumin phospholipid complex or structural analogues of curcumin [48], or the use of a combination of curcumin and piperine.”
BackgroundMultidrug resistance in cancer: role of ATP–dependent transporters
Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536
Targeting multidrug resistance in cancer
Szakács, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C., & Gottesman, M. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1984 · Cited by 3,609
Dai, C.-L., Tiwari, A. K., Wu, C.-P., Su, X.-D., Wang, S.-R., Liu, D.-G., Ashby, C. R., Huang, Y., Robey, R. W., Liang, Y.-J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0499 · Cited by 386
Self-citationCharacterization of P-glycoprotein Inhibition by Major Cannabinoids from Marijuana
Zhu, H.-J., Wang, J.-S., Markowitz, J. S., Donovan, J. L., Gibson, B. B., Gefroh, H. A., & DeVane, C. L. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.098541 · Cited by 192
The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells
Holland, M. L., Panetta, J. A., Hoskins, J. M., Bebawy, M., Roufogalis, B. D., Allen, J. D., & Arnold, J. C. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.12.033 · Cited by 157
The multidrug transporter ABCG2 (BCRP) is inhibited by plant‐derived cannabinoids
Holland, M. L., Lau, D. T. T., Allen, J. D., & Arnold, J. C. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707467 · Cited by 150
Fong, W.-F., Wan, C.-K., Zhu, G.-Y., Chattopadhyay, A., Dey, S., Zhao, Z., & Shen, X.-L. (2007) · Planta Medica · doi:10.1055/s-2007-967120 · Cited by 57
Yoo, H., Lee, M., Lee, M., Lim, S., Shin, J., & Kim, D.-H. (2007) · Planta Medica · doi:10.1055/s-2007-967178 · Cited by 49
Cited by
Multidrug Resistance: An Emerging Crisis
Tanwar, J., Das, S., Fatima, Z., & Hameed, S. (2014) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/2014/541340 · Cited by 657
Mechanisms of drug resistance in colon cancer and its therapeutic strategies
Hu, T., Li, Z., Gao, C.-Y., & Cho, C. H. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i30.6876 · Cited by 381
A Review: The Pharmacology of Isoliquiritigenin
Peng, F., Du, Q., Peng, C., Wang, N., Tang, H., Xie, X., Shen, J., & Chen, J. (2015) · Phytotherapy Research · doi:10.1002/ptr.5348 · Cited by 279
Drug Resistance in Colorectal Cancer: From Mechanism to Clinic
Wang, Q., Shen, X., Chen, G., & Du, J. (2022) · Cancers · doi:10.3390/cancers14122928 · Cited by 160
Candida Efflux ATPases and Antiporters in Clinical Drug Resistance
Prasad, R., Rawal, M. K., & Shah, A. H. (2016) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-25304-6_15 · Cited by 30
Metadata
- Authors
- Wu, C.-P., Ohnuma, S., & V. Ambudkar, S.
- Venue
- Current Pharmaceutical Biotechnology
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2011-04-01
- Volume
- 12
- Issue
- 4
- Pages
- 609-620
- ISSN
- 1389-2010 (ISSN-L)
- OpenAlex
- W2129585034
- Cited by
- 171
- References
- 9
- FWCI
- 4.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Discovering Natural Product Modulators to Overcome Multidrug Resistance in Cancer Chemotherapy. https://app.cochat.ai/papers/10.2174/138920111795163887
- The paper
- Wu, C.-P., Ohnuma, S., & V. Ambudkar, S. (2011). Discovering Natural Product Modulators to Overcome Multidrug Resistance in Cancer Chemotherapy. Current Pharmaceutical Biotechnology. https://doi.org/10.2174/138920111795163887
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.